![]() |
市場調查報告書
商品編碼
2030032
透視設備市場-全球產業規模、佔有率、趨勢、機會與預測:按類型、應用、最終用戶、地區和競爭格局分類,2021-2031年Fluoroscopy Equipment Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球透視設備市場預計將從 2025 年的 67.9 億美元成長到 2031 年的 83.8 億美元,複合年成長率為 3.57%。
透視檢查是一項至關重要的醫學影像技術,它利用X光即時動態地顯示體內結構,使臨床醫生能夠監測器官功能、順利進行介入手術並做出精準診斷。受慢性疾病(包括整形外科和心血管疾病)患病率上升以及對需要持續影像引導的微創手術需求不斷成長的推動,全球透視檢查市場正在顯著擴張。此外,全球人口老化也大大增加了對診斷和治療性介入的需求,進一步推動了市場成長。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 67.9億美元 |
| 市場規模:2031年 | 83.8億美元 |
| 複合年成長率:2026-2031年 | 3.57% |
| 成長最快的細分市場 | X光系統 |
| 最大的市場 | 北美洲 |
儘管劑量降低技術不斷進步,但人們仍然普遍擔憂患者和醫護人員的輻射暴露問題,這仍然是阻礙市場發展的主要障礙。此外,先進透視系統高昂的初始成本和嚴格的監管指南也是其廣泛應用的重大障礙。美國放射學會 (ACR) 在 2025 年 4 月發布的報告中強調了這些系統在診斷成像領域的廣泛應用和持續進步,報告指出其更新後的「適用性標準」涵蓋了 257 項診斷成像和介入放射學項目,涉及約 3700 種臨床場景。
全球透視市場正受到微創手術需求成長的顯著推動,微創手術依賴即時影像技術來進行精準操作。由於微創手術具有許多優勢,例如減輕病患負擔、縮短住院時間和加速復原速度,因此其正逐漸取代傳統開放性手術而日益普及。透視系統能夠在複雜的醫療過程中提供內部結構的即時動態視覺化,在胃腸、整形外科和循環系統等領域的多種介入治療中發揮至關重要的作用。這種持續的微創手術趨勢直接推動了對先進透視設備的需求,這些設備能夠提高手術精度並改善患者預後。正如西門子醫療於2025年11月發布的2025年第四季報告所述,「先進療法」板塊(涵蓋微創手術所需的介入系統)的銷售額實現了3.8%的同店銷售成長。
透視成像技術的持續改進也在推動市場發展,增強了診斷能力,同時解決了輻射暴露等關鍵挑戰。目前的創新重點在於提高影像解析度、降低輻射劑量,並整合人工智慧 (AI) 以簡化工作流程,實現精準的即時評估。這些技術進步正在拓展透視系統的應用範圍,在更廣泛的臨床應用中提升安全性和效率。根據 Impending.ai 2025 年 6 月的一篇報導,飛利浦聲稱其改進的成像技術可以將輻射暴露量降低高達 50%,這是一項重大的技術飛躍,與目前可用的最低劑量設定相比,輻射暴露量可降低 50%。這項持續進步,加上強勁的產業表現,正推動市場維持上升趨勢。例如,AuntMinnie.com 在 2025 年 11 月報道稱,西門子醫療宣布其 2025 年全年銷售額為 233.75 億歐元。
患者和醫護人員持續面臨輻射暴露的擔憂,這是阻礙全球透視市場擴張的主要因素。這一障礙對臨床操作和法規結構均產生重大影響,從而增加了對具備先進劑量降低功能的設備的需求。此外,患者對累積輻射曝射量的焦慮可能導致他們不願意接受長時間或頻繁的透視檢查。
法律規範的加大和報告標準的日益嚴格,不斷加重醫療機構的財務和行政負擔。例如,根據2026年歐洲放射學會(ECR)會議的報告,芬蘭將被要求從2025年起報告其為解決X光應用中的輻射安全缺陷而採取的預防措施,而自2015年以來,芬蘭已記錄了約12920起違規事件。這些嚴格的要求迫使醫療機構在尖端設備方面投入巨資,提供全面的員工培訓,並實施完善的劑量管理平台,從而導致營運成本上升,並減緩了新型透視系統的普及應用。
透視設備市場的一大趨勢是行動式C臂的使用日益普及。這主要得益於其在各種醫療環境中支持影像導引手術的適應性。這些可攜式設備可在臨床環境中即時提供影像,從而改善工作流程和患者管理,最大限度地減少患者移動,並促進微創手術的廣泛應用。這種便利性顯著提高了手術效率和患者的整體治療效果。為了支持這一發展勢頭,根據GE醫療於2026年2月發布的2025年第四季財報,包括透視設備在內的影像業務有機銷售額成長了5.3%。
增強的售後支援和軟體升級也對全球透視市場產生了顯著影響,延長了現有設備的運作並提升了其功能。這包括定期維護、系統校準、旨在提高影像處理精度的軟體更新以及強大的網路安全措施,所有這些都旨在確保最佳性能和符合監管要求。因此,醫療機構無需徹底更換硬體即可最佳化財務回報並順利適應不斷變化的臨床需求。正如GE醫療在2026年2月發布的2025年第四季財報中所強調的那樣,該公司負責軟體及相關服務的先進視覺化解決方案部門實現了4.2%的有機收入成長。
The Global Fluoroscopy Equipment Market is anticipated to expand from USD 6.79 billion in 2025 to USD 8.38 billion by 2031, reflecting a compound annual growth rate (CAGR) of 3.57%. As a vital medical imaging modality, fluoroscopy equipment uses X-rays to produce real-time, dynamic visuals of internal body structures, allowing clinicians to monitor organ function, facilitate interventional procedures, and support accurate diagnoses. The expansion of this global market is largely fueled by the rising incidence of chronic ailments, including orthopedic and cardiovascular disorders, coupled with an increasing preference for minimally invasive surgeries that depend on continuous imaging guidance. Furthermore, the growing elderly population worldwide significantly elevates the need for diagnostic and interventional treatments, driving further market growth.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 6.79 Billion |
| Market Size 2031 | USD 8.38 Billion |
| CAGR 2026-2031 | 3.57% |
| Fastest Growing Segment | Fluoroscopy Systems |
| Largest Market | North America |
A major hurdle hindering market progression is the ongoing worry about radiation exposure for patients and medical staff, even with continuous improvements in dose-reduction technologies. Additionally, the substantial initial costs associated with cutting-edge fluoroscopy systems and strict regulatory guidelines act as significant obstacles to widespread adoption. Highlighting the extensive use and ongoing advancement in the imaging sector served by these systems, the American College of Radiology (ACR) reported in April 2025 that its Appropriateness Criteria update encompassed 257 diagnostic imaging and interventional radiology subjects, addressing almost 3,700 clinical scenarios.
Market Driver
The Global fluoroscopy equipment market is largely propelled by the escalating need for minimally invasive surgeries, which rely on real-time imaging for accurate direction. Such procedures provide multiple advantages, such as minimized patient trauma, decreased hospital durations, and faster recovery periods, leading to their growing favor over conventional open operations. By delivering live, dynamic views of internal anatomy during intricate medical tasks, fluoroscopy systems are crucial for diverse interventions across gastrointestinal, orthopedic, and cardiovascular fields. This sustained inclination toward less invasive methods directly creates a higher demand for sophisticated fluoroscopy machines that improve procedural precision and patient results. As noted by Siemens Healthineers in its Q4 Fiscal Year 2025 report from November 2025, the Advanced Therapies division, encompassing interventional systems vital for minimally invasive surgeries, saw comparable revenue growth of 3.8%.
Ongoing technological enhancements in fluoroscopy imaging also drive the market, tackling vital issues like radiation exposure while boosting diagnostic proficiency. Current innovations emphasize upgrading image resolution, lowering radiation doses, and incorporating artificial intelligence to streamline workflows and deliver precise real-time evaluations. These technological strides broaden the applicability of fluoroscopy systems, rendering them safer and more efficient for a wider spectrum of clinical uses. Underscoring a notable technological leap, a June 2025 article by Impending.ai reported that Philips asserts its revised imaging method could reduce radiation exposure by as much as 50% relative to the lowest-dose settings currently available. This continuous progress, coupled with strong industry outcomes, sustains the market's upward path; for instance, AuntMinnie.com reported in November 2025 that Siemens Healthineers announced its complete fiscal year 2025 revenues reached €23.375 billion.
Market Challenge
The ongoing apprehension regarding radiation exposure for patients and medical personnel acts as a major deterrent to the expansion of the global fluoroscopy equipment market. This obstacle substantially impacts both clinical procedures and regulatory frameworks, stimulating the need for equipment equipped with sophisticated dose-reduction capabilities. Furthermore, patient anxiety about the accumulation of radiation doses may result in a reluctance to undergo extended or frequent fluoroscopic examinations.
Increased regulatory oversight and the enforcement of stricter reporting criteria continuously add to the financial and administrative strain placed on healthcare facilities. For example, observations at the European Congress of Radiology 2026 revealed that beginning in 2025, Finland enforced compulsory reporting for preventive measures addressing radiation safety irregularities in X-ray applications, recording roughly 12,920 deviations since 2015. These strict requirements force facilities to invest heavily in modernized machinery, extensive personnel training, and resilient dose-management platforms, ultimately inflating operational expenses and decelerating the widespread integration of novel fluoroscopy systems.
Market Trends
A prominent trend within the fluoroscopy equipment market is the rising utilization of mobile C-arms, largely driven by their adaptability in supporting image-guided operations in diverse medical environments. By delivering instantaneous imaging right at the point of care, these portable units improve operational workflows and patient management, minimizing the need to move patients and encouraging the growth of minimally invasive procedures. This level of convenience significantly boosts both procedural effectiveness and overall patient outcomes. Demonstrating this momentum, GE HealthCare's Q4 2025 financial report from February 2026 revealed that its Imaging division, which includes fluoroscopy equipment, recorded an organic revenue increase of 5.3%.
The expansion of aftermarket support and software upgrades also has a substantial effect on the global fluoroscopy equipment market by prolonging the operational life and boosting the functionality of existing units. This pattern encompasses routine maintenance, system calibration, software updates aimed at refining image processing, and robust cybersecurity measures, all designed to guarantee peak performance and adherence to regulations. Consequently, medical facilities can optimize their financial returns and smoothly adjust to shifting clinical requirements without needing to completely replace their hardware. As highlighted in GE HealthCare's Q4 2025 financial release published in February 2026, the company's Advanced Visualization Solutions division, responsible for software and associated services, posted an organic revenue growth of 4.2%.
Report Scope
In this report, the Global Fluoroscopy Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Fluoroscopy Equipment Market.
Global Fluoroscopy Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: